Sartorius Stedim Biotech Stock Fundamentals
| 0RG8 Stock | 197.20 6.12 3.20% |
Sartorius Stedim Biotech fundamentals help investors to digest information that contributes to Sartorius Stedim's financial success or failures. It also enables traders to predict the movement of Sartorius Stock. The fundamental analysis module provides a way to measure Sartorius Stedim's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sartorius Stedim stock.
Net Income Applicable To Common Shares is likely to gain to about 1.1 B in 2025, whereas Tax Provision is likely to drop slightly above 86.2 M in 2025. Sartorius | Select Account or Indicator |
Sartorius Stedim Biotech Company Current Valuation Analysis
Sartorius Stedim's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sartorius Stedim Current Valuation | 21.77 B |
Most of Sartorius Stedim's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sartorius Stedim Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sartorius Stedim Biotech has a Current Valuation of 21.77 B. This is 198.95% higher than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The current valuation for all United Kingdom stocks is 30.96% lower than that of the firm.
Sartorius Stedim Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sartorius Stedim's current stock value. Our valuation model uses many indicators to compare Sartorius Stedim value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sartorius Stedim competition to find correlations between indicators driving Sartorius Stedim's intrinsic value. More Info.Sartorius Stedim Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.62 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sartorius Stedim Biotech is roughly 1.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sartorius Stedim's earnings, one of the primary drivers of an investment's value.Sartorius Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sartorius Stedim's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sartorius Stedim could also be used in its relative valuation, which is a method of valuing Sartorius Stedim by comparing valuation metrics of similar companies.Sartorius Stedim is currently under evaluation in current valuation category among its peers.
Sartorius Fundamentals
| Return On Equity | 0.0502 | ||||
| Return On Asset | 0.0313 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 21.77 B | ||||
| Shares Owned By Insiders | 69.70 % | ||||
| Shares Owned By Institutions | 11.54 % | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 1.83 B | ||||
| EBITDA | 645.7 M | ||||
| Net Income | 309.7 M | ||||
| Book Value Per Share | 39.78 X | ||||
| Cash Flow From Operations | 612.3 M | ||||
| Number Of Employees | 10.08 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 36.27 B | ||||
| Retained Earnings | 2.18 B | ||||
| Annual Yield | 0 % |
About Sartorius Stedim Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sartorius Stedim Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Stedim using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Stedim Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 2.2 B | 1.5 B | |
| Cost Of Revenue | 1 B | 711.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Sartorius Stock Analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.